BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Barts Cancer Institute - Queen Mary University of London - ECPv6.14.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Barts Cancer Institute - Queen Mary University of London
X-ORIGINAL-URL:https://www.bci.qmul.ac.uk
X-WR-CALDESC:Events for Barts Cancer Institute - Queen Mary University of London
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20180101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20180322T123000
DTEND;TZID=UTC:20180322T133000
DTSTAMP:20260411T231332
CREATED:20180305T063553Z
LAST-MODIFIED:20180305T063553Z
UID:42-1521721800-1521725400@www.bci.qmul.ac.uk
SUMMARY:Thursday Seminar Series
DESCRIPTION:For this week’s installment of the BCI’s Thursday Seminar Series\, Prof. Mark Cragg – Professor of Experimental Cancer Research and Director of the i4PhD Cancer Immunology Pathway – shall be speaking. Prof. Cragg’s research group is interested in two main areas: antibodies and small molecule inhibitors with the aim of understanding how these therapeutics function to delete tumour cells and how they might be augmented. \nThis seminar shall be in the Lister and Young Seminar Room\, from 12.30pm-1.30pm. \nTitle: TBC \nFor more information about Prof. Mark Cragg\, please click HERE.
URL:https://www.bci.qmul.ac.uk/event/thursday-seminar-series/
CATEGORIES:BCI@CHSQ Seminars
END:VEVENT
END:VCALENDAR